日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions

利用体内慢病毒载体基因疗法治愈1型遗传性酪氨酸血症并预防癌前病变和癌变的发展

Nicolas, Clara T; VanLith, Caitlin J; Hickey, Raymond D; Du, Zeji; Hillin, Lori G; Guthman, Rebekah M; Cao, William J; Haugo, Benjamin; Lillegard, Annika; Roy, Diya; Bhagwate, Aditya; O'Brien, Daniel; Kocher, Jean-Pierre; Kaiser, Robert A; Russell, Stephen J; Lillegard, Joseph B

The future of gene-targeted therapy for hereditary tyrosinemia type 1 as a lead indication among the inborn errors of metabolism

基因靶向治疗在遗传性酪氨酸血症1型(一种先天性代谢缺陷的主要适应症)中的应用前景

Thompson, Whitney S; Mondal, Gourish; Vanlith, Caitlin J; Kaiser, Robert A; Lillegard, Joseph B

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine.

利用慢病毒载体介导的体外肝细胞基因治疗进行猪自体移植

Kaiser Robert A, Mao Shennen A, Glorioso Jaime, Amiot Bruce, Nicolas Clara T, Allen Kari L, Du Zeji, VanLith Caitlin J, Hickey Raymond D, Nyberg Scott L, Lillegard Joseph B